Company intelligence / Profile preview
Dexa Medica
Palembang, South Sumatra, Indonesiadexagroup.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Dexa Medica has evolved from a small company established in 1969 to one of Indonesia's largest ethical pharmaceutical companies. It was the first private Indonesian company to produce nonbranded generics and now manufactures a wide range of oral dosage forms and sterile injectables. The company also collaborates internationally on specialty pharmaceuticals such as triptorelin for endometriosis.
- Therapeutic areas
- Women's Health
- Modalities
- Small moleculesgenericssterile injectables
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Debiopharm (collaboration on triptorelin for endometriosis)
Beyond the preview
Go deeper on Dexa Medica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dexa Medica.